Prospects of new therapeutic approaches for Crohn's disease

被引:6
作者
Hodgson, H [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Dept Gastroenterol, London W12 0HS, England
关键词
D O I
10.1016/S0140-6736(98)00304-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:425 / 426
页数:2
相关论文
共 14 条
[1]   Visualising E-selectin in the detection and evaluation of inflammatory bowel disease [J].
Bhatti, M ;
Chapman, P ;
Peters, M ;
Haskard, D ;
Hodgson, HJF .
GUT, 1998, 43 (01) :40-47
[2]   INTERLEUKIN-1 (IL-1) GENE-EXPRESSION, SYNTHESIS, AND EFFECT OF SPECIFIC IL-1 RECEPTOR BLOCKADE IN RABBIT IMMUNE-COMPLEX COLITIS [J].
COMINELLI, F ;
NAST, CC ;
CLARK, BD ;
SCHINDLER, R ;
LLERENA, R ;
EYSSELEIN, VE ;
THOMPSON, RC ;
DINARELLO, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :972-980
[3]   RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].
ELLIOTT, MJ ;
MAINI, RN ;
FELDMANN, M ;
KALDEN, JR ;
ANTONI, C ;
SMOLEN, JS ;
LEEB, B ;
BREEDVELD, FC ;
MACFARLANE, JD ;
BIJL, H ;
WOODY, JN .
LANCET, 1994, 344 (8930) :1105-1110
[4]  
FEDORAK RN, 1998, GASTROENTEROLOGY, V114, pG3993
[5]   Elevated cell-associated levels of interleukin 1 beta and interleukin 6 in inflamed mucosa of inflammatory bowel disease [J].
GrottrupWolfers, E ;
Moeller, J ;
Karbach, U ;
MullerLissner, S ;
Endres, S .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (02) :115-122
[6]   ATTENUATION OF COLITIS IN THE COTTON-TOP TAMARIN BY ANTI-ALPHA-4 INTEGRIN MONOCLONAL-ANTIBODY [J].
PODOLSKY, DK ;
LOBB, R ;
KING, N ;
BENJAMIN, CD ;
PEPINSKY, B ;
SEHGAL, P ;
DEBEAUMONT, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :372-380
[7]   Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease [J].
Reimund, JM ;
Wittersheim, C ;
Dumont, S ;
Muller, CD ;
Baumann, R ;
Poindron, P ;
Duclos, B .
JOURNAL OF CLINICAL IMMUNOLOGY, 1996, 16 (03) :144-150
[8]   Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease [J].
Satsangi, J ;
Welsh, KI ;
Bunce, M ;
Julier, C ;
Farrant, JM ;
Bell, JI ;
Jewell, DP .
LANCET, 1996, 347 (9010) :1212-1217
[9]   Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease [J].
Stack, WA ;
Mann, SD ;
Roy, AJ ;
Heath, P ;
Sopwith, M ;
Freeman, J ;
Holmes, G ;
Long, R ;
Forbes, A ;
Kamm, MA ;
Hawkey, CJ .
LANCET, 1997, 349 (9051) :521-524
[10]   TUMOR-NECROSIS-FACTOR-ALPHA INTERLEUKIN-1-BETA, AND INTERLEUKIN-6 EXPRESSION IN INFLAMMATORY BOWEL-DISEASE [J].
STEVENS, C ;
WALZ, G ;
SINGARAM, C ;
LIPMAN, ML ;
ZANKER, B ;
MUGGIA, A ;
ANTONIOLI, D ;
PEPPERCORN, MA ;
STROM, TB .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (06) :818-826